Cyclopharm Limited (ASX:CYC)
Australia flag Australia · Delayed Price · Currency is AUD
1.990
+0.060 (3.11%)
Feb 21, 2025, 4:10 PM AEST

Cyclopharm Revenue

Cyclopharm had revenue of 13.21M AUD in the half year ending June 30, 2024, with 15.73% growth. This brings the company's revenue in the last twelve months to 24.06M, down -19.10% year-over-year. In the year 2023, Cyclopharm had annual revenue of 27.14M with 9.19% growth.

Revenue (ttm)
24.06M
Revenue Growth
-19.10%
P/S Ratio
7.83
Revenue / Employee
276.50K
Employees
87
Market Cap
221.16M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202327.14M2.28M9.19%
Dec 31, 202224.85M4.86M24.30%
Dec 31, 202120.00M2.31M13.09%
Dec 31, 202017.68M668.06K3.93%
Dec 31, 201917.01M1.49M9.57%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CSL Limited 24.61B
Pro Medicus 184.58M
Cochlear 2.31B
Sonic Healthcare 9.33B
Telix Pharmaceuticals 783.21M
Ramsay Health Care 16.66B
Ansell 3.00B
Mesoblast 8.85M
Revenue Rankings